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CLINICAL-EPIDEMIOLOGICAL PROFILE OF PATIENTS
WITH COVID-19 TREATED AT A PERUVIAN JUNGLE
HOSPITAL 2020
PERFIL CLÍNICO Y EPIDEMIOLÓGICO EN PACIENTES COVID-19 ATENDIDOS EN UN HOSPITAL
DE LA SELVA PERUANA 2020
Geyner Yonatan Becerra Uriarte1, Hector Eduardo Pardo Lizana 1, Enrique Guillermo Llontop Ynga1, Elmer Lopez-Lopez 1

ABSTRACT
Introduction: The epidemic that had its beginning in the city of Wuhan in December 2019, has become a public
health problem that is advancing at dizzying steps. Objective: To determine the clinical and epidemiological
pro le in Covid-19 patients attended at the HASA-I - Utcubamba, 2020. Methods: The type of research was
observational, descriptive and retrospective cross-sectional. The population consisted of 312 patients from
which a sample of 173 patients was extracted that met the conditions of being representative and adequate. All
data processing and statistical calculations were performed using Microsoft Excel 2019 software. Results:
Regarding the results, it was determined that the epidemiological pro le: male gender a total of 102 and female
gender 71, representing 59,0% and 41,0% respectively; average age of 45 years; most aﬀected place of origin,
the city of Bagua Grande, with a frequency of 162, which represents 93,6%. Regarding the clinical pro le:
diabetes mellitus presented a total of 7 cases, representing 4,1%; cardiovascular diseases with a frequency of 6,
representing 3,5%; general malaise with a total of 75 cases, representing 43,4%; fever with a frequency of 66
cases, representing 38,2%; cough with a frequency of 56 cases, representing 32,4%; headaches with a frequency
of 50 cases, representing 28,9%; and dyspnea with a frequency of 34, representing 19,7%. Conclusion: The male
gender was predominant with comorbidities such as diabetes mellitus, general malaise and elevated CRP.
Keywords: Covid-19; Epidemiology; Comorbidity; Signs and symptoms. (Source: MeSH NLM).

RESUMEN
Introducción: La epidemia que tuvo su inicio en la ciudad de Wuhan en diciembre del 2019, se ha convertido en
un problema de salud pública que avanza a pasos vertiginosos. Objetivo: Determinar el per l clínico y
epidemiológico en pacientes Covid-19 atendidos en el HASA-I - Utcubamba, 2020. Métodos: El tipo de
investigación fue observacional, descriptivo y transversal retrospectivo. La población estuvo constituida por
312 pacientes de la cual se extrajo una muestra de 173 pacientes que cumplía con las condiciones de ser
representativa y adecuada. Todo el procesamiento de datos y cálculos estadísticos se realizaron a través del
software Microsoft Excel 2019. Resultados: En cuanto a los resultados, se determinó que el per l
epidemiológico: género masculino un total de 102 y género femenino 71, representando el 59,0% y el 41,0%
respectivamente; edad promedio de 45 años; lugar de procedencia más afectado, la ciudad de Bagua Grande,
con una frecuencia de 162, la cual representa el 93,6%. Respecto al per l clínico: la diabetes mellitus tipo 2
(DM2) presentó un total de 7 casos, representando el 4,1%; enfermedades cardiovasculares con una frecuencia
de 6, representando el 3,5%; malestar general un total de 75 casos, representando el 43,4%; ebre con una
frecuencia de 66 casos, representando el 38,2%; tos con una frecuencia de 56 casos, representando el 32,4%;
cefaleas con una frecuencia de 50 casos, representando el 28,9%; y disnea con una frecuencia de 34,
representando el 19,7%. Conclusión: El género masculino fue predominante con comorbilidades como DM2,
malestar general y PCR elevada.
Palabras claves: Covid-19; Epidemiología; Comorbilidad; Signos y síntomas. (Fuente: DeCS BIREME).
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INTRODUCTION
The epidemic that began in the city of Wuhan in
December 2019 has become a problem of public health
that advances at vertiginous steps. Its progress was so
overwhelming that, as of March 2020, 114 countries
were aﬀected. Its arrival in the American continent was
reported on January 23, 2020, con rming the rst case
in Argentina, while in Peru, the rst infection was
registered on March 6, 2020 in the city of Lima.
The main problematic reality of underdeveloped
countries such as Peru is related to the fact that not all
departments have standardized reverse transcriptasepolymerase chain reaction (rRT-PCR) tests, which help
in the diagnosis of molecular. Likewise, the poorest
departments and provinces, such as the province of
Utcubamba, did not have vaccines that serve the
speci c antiviral treatment against Covid 19, having as
their only resource non-exposure as a means of
prevention the rational use of equipment. Individual
protection.
Taking all this into account, it is understood that
contagion by this disease involves all the medical
aspects of which it is pertinent to investigate: clinical,
laboratory, and epidemiologica characteristics, to reach
a better understanding of the condition for the sake of
greater and more eﬀective scienti c treatment.
Especially in places that do not have research related to
this current and vital problem, as is the case in Hospital
Apoyo I Santiago Apóstol in the province of Utcubamba
(HSA), which has a large rate of cases that are
progressively increasing, of which The clinical pro le
that would contribute to studying the main
comorbidities that are related to arterial hypertension,
obesity and diabetes mellitus is not yet available;
diseases that could accelerate the progression of the
disease and therefore premature death (5).
Likewise, the HSA of the province of Utcubamba does
not have an epidemiological pro le that allows for
studying morbidity, that is, the evolution of the disease
and its prevalence according to gender, place of origin,
and age. Important data that allow a better knowledge
of the virus and its diﬀerential impact (6) according to
these demographic characteristics.
The objective of this study was to determine the clinical
and epidemiological pro le in Covid-19 patients
treated at the HSA - Utcubamba, 2020.
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METHODS
Type of design and area
An observational, descriptive and cross-sectional study
was carried out. The study area was in Utcubamba,
Amazonas, Perú, the hospital is located in an area called
Bagua Grande.

Population and sample
The population consisted of 312 patients, of which 173
were selected with a con dence level of 95% and 5%
error, of patients diagnosed with Covid-19 treated at the
HSA - Utcubamba during August - December of 2020.
Patients who had positive results using a serological test
or radiological criteria were chosen. Patients with
incomplete or ineligible medical records were
excluded. The sampling was for convenience and the
diagnosis was given by a positive result of the IGG/IGM
rapid test and according to the clinical-radiological
criteria.

Variables and instruments
To execute said investigation, we resorted to the use of
an elaborated technical chart with which the data was
extracted from the conventional clinical histories of
each patient, which speci es the main epidemiological
and clinical characteristics of the patients diagnosed
with Covid-19 treated at the HSA during the months of
August - December 2020. Sociodemographic data such
as age, gender and origin were evaluated. In the clinical
pro le, comorbidities (type II diabetes mellitus,
cardiovascular diseases (heart attack, angina, stroke,
among others), chronic lung disease, ar terial
hypertension, others), clinical signs and symptoms
(general malaise, fever, cough, headache) were
evaluated. , dyspnea, among others) and the laboratory
ndings, the following were considered: High CRP if it
was greater than 10 mg/L, Elevated leukocytes if it was
greater than 4,5 to 11 × 109/L; Lymphopenia if it was less
than 1,5 (5) × 109/L.

Procedure
Permission was requested from the ethics committee of
the university, once its approval was given, permission
was requested from the hospital, which granted
permission to review the hospital le, where data from
the medical records of patients with con rmed
diagnosis of COVID-19 by serological test or PCR. The
data collected was entered into the database at the end
of each day.
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Statistical analysis

Ethical aspects

A database was created in the Microsoft Excel 2019
program, the statistical analysis was carried out in the
STATA 16 program. For the analysis of normality
distribution, the Kolmogorov Smirnov Test was used,
according to this analysis, the variables The qualitative
variables were presented in absolute frequencies and
percentages, the quantitative variables were presented
according to the measures of central tendency (mean,
standard deviation (SD)). Subsequently, all the
quantitative variables were categorized according to
the literature to make them qualitative.

The study was approved by the ethics committee of the
Universidad Señor de Sipán and with authorization
from the HSA management. The data collection forms
were coded to avoid the identi cation of the patients.

RESULTS
A total of 173 patients were reported, most of whom
were male Table 1, with a mean age of 44,7 years (SD
5,8).

Table 1. Gender, age and place of origin of the Covid-19 patients treated
at Hospital Apoyo I Santiago Apóstol – Utcubamba 2020
Characteristics

n

%

Male

102

59,0%

Female

71

41,0%

0 – 11

3

1,7%

12 – 17

6

3,5%

18 – 29

26

15,0%

30 – 59

104

60,1%

60 – 90

34

19,7%

162

93,6%

Cajaruro

6

3,5%

Aramango

2

1,1%

Other

3

1,8%

Gender

Age

Place of origin
Bagua grande

Source: Personal elaboration. Data collection sheet of the epidemiological and clinical characteristics
of the Covid-19 patients treated at Hospital Apoyo I Santiago Apóstol - Utcubamba 2020

22 patients with comorbidities were found, of these the highest frequency was diabetes
mellitus, the rest of the patients did not presented comorbidities (Table 2).

Table 2. Most recurrent comorbidities of Covid-19 patients treated at Hospital Apoyo I
Santiago Apóstol - Utcubamba 2020.
Comorbidity

n

%

Type II diabetes mellitus

7

4,1

Cardiovascular disease

6

3,5

Chronic lung disease

3

1,7

Hypertension arterial

2

1,2

Other

4

2,4

(heart attack, angina, stroke, etc.)

Source: Personal elaboration. Data collection sheet of the epidemiological and clinical characteristics
of the Covid-19 patients treated at Hospital Apoyo I Santiago Apóstol - Utcubamba 2020
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The most frequent signs or symptoms were general malaise and fever, the least
frequent were nausea or vomiting. Table 3

Table 3. Signs and symptoms of Covid-19 patients treated at Hospital Apoyo
I Santiago Apóstol - Utcubamba 2020.
Sign or symptom

n

%

General malaise

75

43,4

Fever

66

38,2

Cough

56

32,4

Headaches

50

28,9

Dyspnea

34

19,7

Changes in taste and

31

17,9

Odinophagia and runny nose

18

10,4

Diarrhea

10

5,8

Nausea and vomiting

7

4,1

smell

Source: Personal elaboration. Data collection sheet of the epidemiological and clinical characteristics
of the Covid-19 patients treated at the Hospital Apoyo I
Santiago Apóstol - Utcubamba 2020

Table 4. Laboratory

ndings in the patients Covid-19 treated at the
Hospital Apoyo I Santiago Apóstol - Utcubamba 2020.

Laboratory ndings

n

%

C-reactive protein Elevated

10

7,3

Leukocytes

10

7,3

Lymphopenia

0

3,5

Others

0

0

DISCUSSION

Regarding gender, the highest prevalence (3,5,7,8) in the

Currently, Covid-19 is considered one of the most
dismal pandemics in history, not only because of the
abrupt increases in mortality rates throughout the
world but also because of the symptoms and
comorbidities that it can trigger, these being painful
and lethal. Epidemiological and clinical studies are still
an open eld due to the variants that this disease has
developed, which continue to mutate and continue to
express themselves in diﬀerent clinical manifestations
and laboratory ndings.

male gender since they have a greater genetic

In the present investigation, it was possible to identify
the epidemiological characteristics that include the
gender, age, and place of origin of the AHS patients.
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predisposition to (9,10) contract this type of disease. The
average age in general, was 44,7 years, with adults and
older adults being the most aﬀected. These results were
partially similar in other studies, indicating that the
disease tends to have a greater impact on these people
because the immune system (8,12) deteriorates over time.
Regarding the place of origin, 93,6% resided in the city
of Bagua Grande, the capital of Utcubamba, which
represents a greater centralization of people and an (5,12).
a higher risk of contagion.
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Regarding the main comorbidities presented in HSA
Covid-19 patients, diabetes mellitus, cardiovascular
diseases, and (5,12) high blood pressure stood out, which
generated an unfavorable clinical course due to the
weakening of the(8) immune and circulatory system.
Consequently, it was possible to identify the symptoms
and signs presented by SAH patients, the main one
being general malaise, characterized by (13) fatigue and
diﬀuse pain were also present. Fever and cough (9,14)
Covid-19. Likewise, dyspnea and headaches can occur
due to a lack of oxygen and (15) blood supply.
Regarding the identi cation of the rst laboratory
ndings, which have been the study material of many
investigations, elevated CRP, elevated leukocytosis, and
lymphopenia were found, ndings (16) that are shared by
other investigations because they are samples that
represent the presence of infections at the blood level
and product of the deformation of antibodies that help
(17)
ght this microorganism.

The limitations of the research were the small sample
compared to the studies carried out at a national and
international level. Likewise, the study was only carried
out at a retrospective and descriptive level. However, it
represents the rst study carried out in the HSA and in
the province of Utcubamba. Another limitation arose in
the equipment of the laboratory instruments that were
required to carry out more speci c tests; however, the
most basic and necessary ones could be carried out
with the help of the medical and administrative
personnel who provided the required information at all
times.

CONCLUSIONS
The epidemiological and clinical pro le of the HSA
Covid 19 patients were: Predominantly male gender
with an average age of 44,7 years; the most aﬀected
place of origin, the city of Bagua Grande. According to
main comorbidities: Diabetes Mellitus. According to
main signs and symptoms: malaise, according to main
l a b o r a t o r y n d i n g s : e l e v a t e d C R P, e l e v a t e d
leukocytosis, and lymphopenia.
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